GreenSky Capital Inc.
6 Adelaide St E M5C 1H6 Toronto, ON, Canada

GreenSky Accelerator Fund III Invests in ProNavigator GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III has co-led a $5.6M financing in ProNav Technologies Ltd. (ProNavigator). ProNavigator is an insurance technology company that helps leading carriers and brokerages overcome information barriers. Other investors in the round were Luge Capital, MaRS Investment Accelerator Fund, iNovia Capital, BDC, and CIBC Innovation Capital. This round brings the company’s total amount raised to $7.8 million. The new capital will be used to hire key resources to power expanded operations in the U.S. and Canada, and to extend ProNavigator’s product line. Read more: https://greenskycapital.com/greensky-accelerator-fund-iii-/

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future Cyclica, a neo biotech company, announced today the close of a CAD$23M Series B round of financing. The round was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital, and members of Cyclicas management team. Cyclica is decentralizing the discovery of better medicines by combining its deep roots in Artificial Intelligence (AI) and protein biophysic...s with an innovative business model. To drive sustainable progress in reducing attrition rates and timelines to the clinic, Cyclica believes that an avant-garde and holistic approach to drug discovery, both scientifically and commercially, is required. Read the full press release: https://greenskycapital.com/cyclica-raises-cad23-million-i/

GreenSky Capital Leads $1.5M Investment in Funnelytics GreenSky Capital Inc. is very pleased to announce that the GreenSky Accelerator Fund III, LP has co-led a $1.5M seed financing round in Funnelytics Inc. with the MaRS Investment Accelerator Fund. Additional investors include Good News Ventures, members of the GreenSky Presidents Club, and other local angels. Read more here: https://greenskycapital.com/greensky-capital-leads-1-5m-in/

Pyrowave Closes Series B GreenSky Capital is proud to announce that Pyrowave Inc., a portfolio company of GreenSky Accelerator Fund I and the GreenSky Presidents Club angel group, has closed a Series B round led by strategic partner Michelin and Sofinnova Partners. Read more: https://greenskycapital.com/pyrowave-closes-series-b/

GreenSky Accelerator Funds Invest in Payment Rails GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III, has made a $950,000 investment as part of a bridge round in Payment Rails Inc. Also participating in the round were members of the GreenSky Presidents Club, an affiliated angel network. Read more: https://greenskycapital.com/greensky-accelerator-funds-inv/

GreenSky Capital Inc. is very pleased to announce the final close of its third affiliated venture fund, the GreenSky Accelerator Fund III, LP. The Fund has $8.5 million to be invested in Canadian early-stage technology companies. The Funds limited partners are composed of a network of private Canadian and U.S. investors, many of whom are repeat GreenSky partners or were introduced to GreenSky by investors in the two previous funds. GreenSky is excited to announce promotions ...to two of its core staff members. Neil Peet, who joined the company as an Analyst in 2015 and most recently served as Senior Associate, has been promoted to Principal. GreenSky also promoted Valdis Martinsons, from Director of Technology Evaluation, to Partner. Read more: https://www.greenskycapital.com/greensky-capital-closes-gr/

GreenSky Capital Leads $1.25M Investment in Direct-C GreenSky Capital Inc. (GreenSky) is very pleased to announce that the GreenSky Accelerator Fund III, LP (the Fund) has led a $1.25M Seed financing round for Direct-C Ltd, with members of the GreenSky Presidents Club and Direct-C management filling out the round. Direct-C has created a breakthrough proprietary nanocomposite coating based on compounds specifically designed to react only to liquid hydrocarbons. The end re...sult is a leak detection solution that provides unparalleled performance for monitoring the integrity of oil and gas infrastructure with zero false positives, instant alerts, and precise locations all of which lead to enhanced response times to unexpected incidents. Originally developed at the University of Calgarys Schulich School of Engineering, Direct-Cs head office is located in Edmonton with satellite offices located in Calgary and Bath, England. Read more: https://www.greenskycapital.com/greensky-capital-leads-1-2/

GreenSky Capital Inc. is pleased to announce that its affiliated venture fund, the GreenSky Accelerator Fund III, has led a $1.85 million equity investment round in RANK Software Inc. The financing included participation from the GreenSky Accelerator Fund III, members of the affiliated angel group, the GreenSky Presidents Club, Generation Ventures and MaRS Investment Accelerator Fund, both of which have previously invested in RANK Software. You can read more at: https://www.greenskycapital.com/rank-software-closes-a-1-/

Akira Health Acquired by Telus On July 31, 2019, Telus Health acquired Akira Health (Akira), a portfolio company of the GreenSky Accelerator Fund I, for undisclosed terms. The GreenSky Accelerator Fund I had invested in Akira in 2017. Read more: https://www.greenskycapital.com/akira-health-acquired-by-t/

On July 1, 2019, H&R Block acquired Wave Financial, Financial Inc. (Wave) for C$536M. Wave had been a client of GreenSky Capital in its previous incarnation as a broker/dealer. At that time, GreenSky advised Wave raise its first investment round from members of the GreenSky Presidents Club, an Ontario-registered angel group, as well as its first institutional round of financing. GreenSky is now affiliated with and manages several venture capital funds. Read more: https://www.greenskycapital.com/wave-financial-acquired-by/

Cyclica: the subject of a recent Financial Post Article A recent Financial Post article prominently showcased two Canadian companies Cyclica and Deep Genomics who are at the forefront of applying Artificial Intelligence in the field of drug discovery and innovation. Read more: https://www.greenskycapital.com/cyclica-subject-recent-fin/

Pyrowave: the subject of a recent CBC Report A recent CBC report showcased Pyrowave as one of three companies in Canada aiming to address the problem of how to efficiently recycle styrofoam. As the CBC report noted, 80 percent of styrofoam waste in Canada and 94 per cent in the United States is not currently being recycled. Pyrowave is seeking to improve these rates through its microwave technology, which can treat dirtier styrofoam than traditional recycling, and which gener...ates new styrofoam with 100 per cent recycled content that's identical to 'new' styrofoam made directly from petroleum. Read more: https://www.greenskycapital.com/pyrowave-subject-recent-cb/

AI-powered Insurtech ProNavigator Closes 2 Million Equity Financing ProNavigator, a technology platform company using artificial intelligence (AI) to reinvent the customer experience and drive growth in the insurance industry, has closed its latest seed round of equity financing, bringing its total funding to over $2 million. The round was co-led by GreenSky the Capital MaRS Investment Accelerator Fund (IAF). The financing included participation from Innovation Grade Ventures and a select group of prominent angel investors from the Waterloo-Toronto corridor. Read more: https://www.greenskycapital.com/ai-powered-insurtech-prona/

Cyclica drives new research capabilities for Merck KGaA, Darmstadt, Germany, through its AI Augmented Screening Platform Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that it has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express, a cloud-based in silico proteome screening platform. Ligand Express is a structure-based and artificial intelligence (AI) augmented proteome screening platform that is being use...d to uncover novel targets that are modelled to interact with a small molecule. This year-long agreement will enable Merck KGaA, Darmstadt, Germany to quickly and efficiently elucidate mechanisms of action, evaluate safety profiles and explore additional applications for a number of its investigational small molecules, including those identified in highly disease-relevant phenotypic screens. Read more: https://www.greenskycapital.com/cyclica-drives-new-researc/

Cyclica Drives Drug Discovery Through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer Cyclica Inc., a Bayer G4A company, is pleased to announce a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small molecules, while further evolving Cyclicas integrated network of enabling technologies. Read more: https://www.greenskycapital.com/cyclica-drives-drug-discov/

Nanovista Appoints Dr. Vincent Lenaerts As New CEO GreenSky Capital Inc. is very pleased to welcome Dr. Vincent Lenaerts as the new Chief Executive Officer of Nanovista Inc. Dr. Lenaerts has executive experience in a variety of fields including nanotechnologies, drug delivery, diagnostics, peptides, endocrinology, ophthalmology and oncology and has held CEO positions at Miraculins, Bioxalis Medica and Apidel in Switzerland. Dr. Lenaerts has a Bachelor of Pharmacy, a Master of... Science in Industrial Pharmacy and a Ph.D. in Pharmaceutical Sciences from the University of Louvain. Read more: https://www.greenskycapital.com/nanovista-appoints-dr-vinc/

GreenSky Accelerator Funds Invest in Weever Apps GreenSky Capital Inc. is pleased to announce that its affiliated venture funds, the GreenSky Accelerator Funds I and II, have led a $900K equity investment in Weever Apps in syndicate with members of the GreenSky Presidents Club. Weever is a Hamilton-based software company that makes technology to simplify processes on factory floors. They provide electronic forms, process and inspection software, digitizing much of the paperw...ork still found on many manufacturing floors. Weever has strong traction with several of the largest manufacturers in North America and has proven adept at expanding within customers, growing to new facilities and adding functionality and products at existing facilities. Prior to the Funds investment, Weever had raised capital through angel investors. This first institutional round of financing will support rapid growth and complete a business model transition from project-oriented revenue to Software as a Service. https://www.greenskycapital.com/greensky-accelerator-funds/

AOMS Technologies Announces the Launch of LumiCon, a New Generation of Concrete Sensors AOMS Technologies Inc. announced the launch of LumiCon, an in-situ distributed concrete monitoring platform using AOMS patented Fiber Optic Sensing Technology (AOMS-FOS). AOMS LumiCon system enables general contractors and ready-mix concrete producers to remotely collect continuous, distributed, and real-time temperature and moisture data from many job sites simultaneously to help with... controlling the curing conditions of the concrete efficiently, managing the maximum internal and differential temperature in mass concrete placements, and more importantly, measuring the maturity of concrete versus time. The real-time information provided by LumiCon eliminates the need for trips to job sites to collect data or samples for testing, which improves quality, minimizes delays and reduces on-site labor cost. Read more: https://www.greenskycapital.com/aoms-technologies-announce/

Pyrowave Receives First Investment of Export Development Canadas new Cleantech Co-Investment Program Toronto July 9, 2018 // GreenSky Capital is proud to announce that Pyrowave Inc., which uses its unique microwave technology to process plastic waste, will receive a $1-million investment under Export Development Canadas (EDC) new Cleantech Co-Investment Program. It is the first investment of the program. https://www.greenskycapital.com/pyrowave-receives-first-in/

The Top Barrier To AI In Drug Discovery May Surprise You https://www.greenskycapital.com/top-barrier-ai-drug-discov/ Source from forbes.com: https://www.forbes.com//the-top-barrier-to-ai-in-drug-di/

GreenSky Accelerator Funds Invest in Nanovista Toronto, ON February 12th, 2018 GreenSky Capital Inc. is pleased to announce that its affiliated venture funds, the GreenSky Accelerator Fund I and GreenSky Accelerator Fund II, have made a $750,000 lead investment as part of a $2.3M seed round investment in Nanovista Inc. (Nanovista).... https://www.greenskycapital.com/greensky-accelerator-funds/

Cyclica Launches Ligand Express, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery GreenSky Capital client Cyclica is launching its novel cloud-based, proteome screening platform, Ligand Express. The unique platform, which harnesses biophysics, biological data, and artificial intelligence (AI), is actively being used by pharmaceutical scientists to more efficiently navigate the drug discovery pipeline.

Pyrowave, Inc. named Global Cleantech 100 to Watch Pyrowave Inc., a GreenSky Capital client, has been named one of 2017 Global Cleantech 100 Ones to Watch list. Produced by Cleantech Group (CTG), the Ones to Watch list seeks to highlight a group of up-and-coming companies that are catching the eye of leading investors and corporates in the market. https://www.greenskycapital.com/pyrowave-inc-named-global-/

GreenSky Accelerator Funds Invest in EcoService GreenSky Capital Inc. is pleased to announce that its affiliated venture funds, the GreenSky Accelerator Fund I and II have made a USD$500,000 investment as part of a follow-on Seed round in JDH EcoService Inc. ("EcoService"). https://www.greenskycapital.com/greensky-accelerator-funds/

GreenSky Accelerator Fund II $5M Initial Launch; Leads $2.25M Series A2 Investment in Cyclica GreenSky Capital Inc. (GreenSky) is pleased to announce the launch of its second affiliated Canadian early-stage venture fund, the GreenSky Accelerator Fund II, LP (Fund II). Fund II is also pleased to announce that it has made its first investment, as lead investor, in the $2.25M Series A2 financing of Cyclica Inc., which is an extension of the $2.4M Series A1 financing round ...that closed in September 2016. Read the full press release here: https://www.greenskycapital.com/greensky-accelerator-fund-/

Toronto is the Fastest Growing Tech Market in North America via Techvibes: https://techvibes.com//toronto-is-the-fastest-growing-tech Toronto has been named the fastest growing tech market in North America by the CBREs 2017 North American Scoring Tech Talent report. The city even beat out the technology hotbeds of San Francisco and New York City combined, shooting up from 12th to sixth in an overall annual ranking.... https://www.greenskycapital.com/toronto-is-the-fastest-gro/

GreenSky Client Pyrowave Wins First Place at International Chemistry and Materials Conference Montreal, QC GreenSky Capital is proud to announce that Pyrowave Inc. won first prize at the 6th edition of the IQ-Chem International Chemistry Innovation Competition organized by SIBUR, one of the largest chemical group in Moscow, Russia. In total, 251 teams from 27 countries took part in the international IQ-CHEM contest which was judged by a panel comprised of directors and executives from companies such as The Dow Chemical Company, Linde, LG, Honeywell UOP, DuPont, 3M, BASF and Sinopec. Pyrowave, which is based out of Montreal, QC and Oakville, ON, raised a seed round through the GreenSky Presidents Club in 2015. https://www.greenskycapital.com/greensky-client-pyrowave-wi

Mirexus Biotechnologies Inc. Raises $12 million to Finance Factory, Fund Business Development, Deepen R&D GreenSky Capital Inc. (GreenSky) is happy to announce that Mirexus Biotechnologies Inc. (Mirexus) has closed a $12 million investment round. Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherixTM, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics and nutraceuticals to applications in human health. Read more: https://www.greenskycapital.com/mirexus-biotechnologies-in/

AOMS closes second half of $925,000 Seed Financing Round Advanced Opto-Mechanical Systems and Technologies Inc. (AOMS) is pleased to announce that it has closed an additional $425,000 in financing on the same terms on which its lead investor, the GreenSky Accelerator Fund I, invested $500,000 in December 2016. AOMS will use these funds to bring its proprietary fibre optic sensor technology to market and to expand innovation through continued product development. Ontario Centres of Excellence (OCE) co-invested $125,000 through their Market Readiness Customer Creation program and $300,000 was procured through the GreenSky Presidents Club, GreenSky Capitals affiliated angel network.

AOMS Technologies closes $500,000 in Seed Financing through GreenSky Capital GreenSky Capital Inc. (GreenSky) is pleased to announce that Advanced Opto-Mechanical Systems and Technologies Inc. (AOMS), a company that has developed a proprietary fibre optic sensor technology capable of measuring multiple parameters in harsh conditions, has closed the first $500,000 of its seed round financing with the GreenSky Accelerator Fund I, LP (the GreenSky Fund). AOMS expects to raise up to an additional $500,000 in further financing from additional investors associated with the GreenSky Presidents Club (the GPC). The funds will enable the company to scale up its sales and marketing efforts, and expand innovation through continued product development. http://www.greenskycapital.com/aoms-closes-500000-in-seed-/

Pyrowave Inc., a GreenSky Capital client, has been nominated as one of the 10 finalists in the Startup category of the 2017 GreenTec Awards, one of the worlds largest environmental business contests. Three finalists will be invited to the GreenTec Gala in Berlin and individual votes can influence the selection process: the project that receives the most online votes automatically qualifies as one of the three nominees of its category. Pyrowave is proud to be part of the Gre...enSky portfolio. GreenSky was an early proponent of our technology and was critical in helping us secure our early stage financing, said, Jocelyn Doucet CEO of Pyrowave. With this international recognition, we hope to focus additional global attention on the important work we are doing to help find economically sustainable and environmentally responsible recycling solutions. View the full press release: http://pyrowave.com/?p=518 Vote for Pyrowave here: http://abstimmung.greentec-awards.com/?lang=en

Cyclica, an *in silico* drug discovery company that offers a novel predictive analytics platform that helps develop better and safer drugs, announced that it has completed a $2.4 Million Series A1 financing. The syndicated round was led by Toronto-based GreenSky through the GreenSky Accelerator Fund I, LP, with additional investment from both existing and new investors, including the China Canada Angel Alliance, and the family of Mr. Anthony Griffiths. The funds will enable the company to scale up its sales and marketing efforts, and expand innovation through continued product development. http://www.greenskycapital.com/cyclica-inc-completes-2-4-m/

GreenSky Capitals EVE Program Gives Students Real World Venture Capital Experience Toronto, ON September 6, 2016 Earlier this year, GreenSky Capital Inc. (GreenSky) launched the Early Venture Evaluation (EVE) Internship Program. EVE is designed to expose students to the full range of the deep due diligence process at venture capital firms. With guidance from GreenSky team members, graduate students prepare a draft due diligence report on a single company that GreenSk...y has engaged as a potential investee. They present their findings internally to the partners at GreenSky, and a final version of the report is made available to GreenSkys co-investors. http://www.greenskycapital.com/greensky-capitals-eve-progr/